Cited by 900Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMedicinal Plants and Neuroprotection

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.

Global estimates on the number of persons across the Alzheimer's disease continuum

Open access

Gustavsson, Anders, Norton, Nicholas, Fast, Thomas, Frölich, Lutz, Georges, Jean, Holzapfel, Drew, Kirabali, Tunahan, Krolak‐Salmon, Pierre, Rossini, Paolo M., Ferretti, Maria Teresa, Lanman, Lydia, Chadha, Antonella Santuccione, van der Flier, Wiesje M.·2023·Alzheimer's & Dementia

DOI 10.1002/alz.12694

Open this paper in CoChat — free account Open PDF

Abstract

Introduction: Global estimates on numbers of persons in early stages of Alzheimer's disease (AD), including prodromal and preclinical, are lacking, yet are needed to inform policy decisions on preventive measures and planning for future therapies targeting AD pathology. Methods: We synthesized the literature on prevalence across the AD continuum and derived a model estimating the number of persons, stratified by 5‐year age groups, sex, and disease stage (AD dementia, prodromal AD, and preclinical AD). Results: The global number of persons with AD dementia, prodromal AD, and preclinical AD were estimated at 32, 69, and 315 million, respectively. Together they constituted 416 million across the AD continuum, or 22% of all persons aged 50 and above. Discussion: Considering predementia stages, the number of persons with AD is much larger than conveyed in available literature. Our estimates are uncertain, especially for predementia stages in low‐ and middle‐income regions where biomarker studies are missing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/alz.12694

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
Retracted
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
Mild cognitive impairment – Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment.
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689

Show all 62 references

Research works printed but not linked: 3

WHO, 2019, Risk reduction of cognitive decline and dementia: WHO guidelines, Geneva: World Health Organization
American Psychiatric Association Diagnostic and statistical manual of mental disorders.2000(4th edition).
WHO, 2021, Global status report on the public health response to dementia, Geneva: World Health Organization

Sorted by citations

Items 601–700 of 900

The role of galanin/GALR2 signaling in the link between type 2 diabetes and Alzheimer's disease
Xu, M., Wang, J., She, Y., He, J., Yu, M., Zhang, Z., & Fang, P. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102586 · Cited by 1
From Limb to Brain: Lymphedema as a Systemic Disease with Metabolic, Immunological, and Neurodegenerative Consequences and the Disease-Modifying Potential of Lymphaticovenous Anastomosis—An Integrative Analysis
Yang, J. C. (2026) · Seminars in Plastic Surgery · doi:10.1055/a-2780-1561 · Cited by 1
Butyrate antagonizes Annexin A2–mediated tauopathy via Annexin A1 reciprocity in Alzheimer's disease
Jayaswamy, P. K., Ambrish, T., Sangamesh, V. C., Kellarai, A., Patil, P., Alexander, L. M., & Shetty, P. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.115968 · Cited by 1
Porphyromonas gingivalis in Alzheimer’s disease: Association with salivary lactoferrin and inflammatory response
Antequera, D., Carrero, L., Romualdi, D., Buetas, E., García‐Consuegra, I., Cantero, J. L., Mira, A., Municio, C., & Carro, E. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119112 · Cited by 1
RNA isoform diversity, splicing variants and switching in single cells of the Alzheimer’s disease brain
Shahnaee, A., Liu, C. S., Ngo, T., Palmer, C. R., Ziomek, D., Park, C. S., Tan, V. P., Jimenez, N. A., & Chun, J. J. M. (2026) · Communications Biology · doi:10.1038/s42003-026-09759-9 · Cited by 1
Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer’s disease
Rodriguez, Q., Payet, F., Vargas-Baron, K., Borel, E., Lanté, F., Boisseau, S., Blot, B., Girault, J., & Buisson, A. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00021-4 · Cited by 1
Molecular Mechanisms Underlying the Alleviation of Aβ‐Induced Toxicity by Edible Flower Buds of Hemerocallis citrina in Caenorhabditis elegans
Liu, C., Wang, X., Yang, Y., Li, H., Yang, J., Jiang, H., Guo, L., Lu, Y., Zhang, Z., & Fei, D. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202503362 · Cited by 1
Novel Monoclonal Antibody Detects Small Aβ Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media
Xu, Y. R., Tao, Y., Lish, A. M., Li, S., Ostaszewski, B. L., Anderson, A. K., Young‐Pearse, T. L., Lawton, T., Yang, H., Walsh, D. M., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78196 · Cited by 1
Ultrasensitive chemiluminescent detection of plasma Aβ1-40 based on soluble macromolecular signal amplification carrier
Guo, C., Liu, M., An, Z., Li, S., Cui, M., Nie, J., Sun, Y., & Bai, Z. (2026) · Talanta · doi:10.1016/j.talanta.2026.129688 · Cited by 1
Identifying candidate gut microbiota indicators for Alzheimer’s disease through integrated data
Wang, J., Liu, H., Lai, H., Bao, Y., Shen, M., Li, C., Ma, L., Wu, T., Yang, S., Du, X., et al. (2026) · mSystems · doi:10.1128/msystems.01754-25 · Cited by 1
Plasma EV LINE-1 mRNA as a diagnostic biomarker for differentiating Alzheimer’s disease from non-Alzheimer’s dementias
Li, M., Yu, Q., Yu, S., Cheng, Q., Wu, S., Jin, Y., Cui, Z., Chen, H., Zhao, X., Wu, X., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02034-3 · Cited by 1
Advances in hiPSC ‐Derived Brain Organoids as a Model to Study Neuroinflammation in Alzheimer's Disease
Maciel, E. M. A., Silva, N. C., Santos, L. G. P., & Ribeiro, F. M. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70416 · Cited by 1
Increase in healthcare utilization and Medicare payment with progression of preclinical Alzheimer’s disease
Beyrer, J. K., Sheff, Z. T., Payakachat, N., Chandler, J., Chen, Y.-F., Kubisiak, J. M., Lee, A., Holdridge, K. C., Yaari, R., Aisen, P. S. S., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100547 · Cited by 1
Ensemble-Based Estimation of Alzheimer’s Disease Incidence from Dynamic Population Reconstructions
Bertaglia, G., Iacomini, E., & Viguerie, A. (2026) · SIAM Journal on Life Sciences · doi:10.1137/25m1782522 · Cited by 1
Longitudinal Evaluation of 18 F-MK-6240 Along the Alzheimer Disease Continuum
Giarratana, A. O., Jonaitis, E. M., Przybelski, R. J., Cody, K. A., Betthauser, T. J., Cadman, R. V., Alberson, S. F., Christian, B. T., & Johnson, S. C. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.271127 · Cited by 1
Design and Validation of a Multimodal Immersive Virtual Environment for Cognitive Intervention in Patients with Alzheimer’s Disease
Deng, H., Shang, Y., Zhang, F., Qian, Z., Chen, K., & Wang, H. (2026) · IEEE Conference on Virtual Reality and 3D User Interfaces (VR) · doi:10.1109/vr67842.2026.00033 · Cited by 1
Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
Cummings, J. L., Agadjanyan, M. G., Barry, M., Corey, L., Doody, R., Hendrix, S. B., Mattke, S., Mattsson, N., McDade, E., Menetski, J. P., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04305-w · Cited by 3
Hypolipidemics reduce the rate of Alzheimer's disease development and dementia progression: A cohort study linked with genetic and neuropathological analyses
Sternberg, Z., Podolsky, R., Yu, J., Hua, S., Halvorsen, S. W., & Schaller, B. J. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100555 · Cited by 1
Guiding approaches to studying Alzheimer’s disease: a scoping review of community engagement, health communication, and implementation science research
Yelton, B., Workman, L. M., Schaurer, L., Riccardi, N., McCollum, Q., Belza, B. L., Ory, M. G., Thorpe, R. J., Wheeler, S. B., Trinh‐Shevrin, C., et al. (2026) · The Gerontologist · doi:10.1093/geront/gnag056 · Cited by 1
Integrating Acridinium Ester with a Soluble Macromolecular Amplification Carrier for Ultrasensitive Detection of Aβ1-42 in Plasma
Guo, C., Liu, M., An, Z., Li, S., Cui, M., Nie, J., Sun, Y., & Bai, Z. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c00193 · Cited by 1
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1
Ultraprocessed Foods and the Aging Brain: State of the Science
Carmichael, O. T., Agarwal, P., Albensi, B. C., Balendra, V., D'Cunha, N. M., Denier‐Fields, D. N., Ferreira, N. V., Gonçalves, N. G., Kumar, R., Labyak, C. A., et al. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061824-053453 · Cited by 1
Safety, tolerability and immunogenicity of vaccine ALZ-101 in patients with early Alzheimer’s disease: randomised, controlled trial
Lovró, Z., Sandberg, A., Zetterberg, H., Pierrou, S. E., Parkkola, R., Sjögren, N., Scheinin, M., & Rinne, J. O. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02082-9 · Cited by 2
Diagnostic and Prognostic Utility of Plasma p‐tau217 for Alzheimer's Disease in Chinese Elderly: Insights From the SILCODE Study With a Derived Threshold
Li, R., Yang, J., Chai, W., Liu, H., Wang, X. G., Zhang, S., Cai, H., Wang, J., Guo, T., & Han, Y. (2026) · European Journal of Neurology · doi:10.1111/ene.70618 · Cited by 1
Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease
Skrehot, J. T., & Kurouski, D. (2026) · Protein Science · doi:10.1002/pro.70635 · Cited by 2
Novel hydroxytyrosol esters as potential anti-amyloid and neuroprotective agents for Alzheimer's disease
Kalpaktsi, I., Panara, A., Mavroidi, B., Niforos, G., Kalampaliki, A. D., Vlachogianni, I. C., Georgiou, E. A., Fragopoulou, E., Tsarbopoulos, A., Skaltsounis, A., et al. (2026) · RSC Medicinal Chemistry · doi:10.1039/d6md00265j · Cited by 1
Machine Learning‐Enhanced Ultrasensitive Immuno‐CRISPR Array Facilitates Early Diagnosis of Alzheimer's Disease by Detecting Multiple Plasma Biomarkers
Zhang, L., Yang, C., Yao, Q., Du, X., Ding, S., Shi, Y., Sheng, C., Wang, M., Han, Y., & Luo, H. (2026) · Advanced Science · doi:10.1002/advs.75983 · Cited by 2
Detecting amyloid–β pathology in subjective cognitive decline using plasma and CSF biomarkers
Contador, J., Pozzi, F. E., Sánchez‐Benavides, G., Fernández‐Arcos, A., Lantero‐Rodriguez, J., Montoliu‐Gaya, L., Minguillón, C., Fauria, K., González‐Escalante, A., Ortiz‐Romero, P., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106331 · Cited by 2
Alzheimer’s Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies
Kashif, M., & Majumder, D. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06009-1 · Cited by 1
Rethinking Alzheimer's Disease Therapy: From Amyloid‐Centric Approaches to Multi‐Target Phytochemical Strategies
Aktaş, E., Yurt, İ., Cerlet, Y. N., & Hanagasi, H. A. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70506 · Cited by 1
Projected effect of a high performing blood test on wait times for determination of Alzheimer's disease pathology in the United States
Mattke, S., Chen, J., Hanson, M. S., Johnson, K. G., Leahy, C., Merrill, D. A., Shada, V., & Ruiz, J. G. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261467345 · Cited by 1
Novel benzensulfonamide-linked oxadiazole-pyridine hybrids as dual acetylcholinesterase and butyrylcholinesterase inhibitors: Design, synthesis, biological evaluation and computational studies
Hassan, R. M., Abdel‐Maksoud, M. S., Ibrahim, I. M., El-Garhy, M. R., Farouk, F., Hamissa, M. F., Husein, D. Z., & Ghannam, I. A. Y. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.147362 · Cited by 1
Spatial lipidomics of the human brain: systematic review of current state and future perspectives
Cabasino, C., Enrico, P., Bottaro, F., Santis, D. D., Cagnoli, C. M., Garbelli, R., Bongarzone, I., Torrente, Y., Delvecchio, G., & Brambilla, P. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03793-z · Cited by 1
The conundrum of the AD continuum
Daly, T. P. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12783 · Cited by 1
Neuropathological changes in the TASTPM mouse model of Alzheimer’s disease and their relation to hyperexcitability and cortical spreading depolarization
Gimeno-Ferrer, F., Eitner, A., Noora, N., Bauer, R., Schmidt‐Hieber, C., Schaible, H., & Richter, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-57868-4 · Cited by 2
DOSE: a lifestyle philosophy for dementia prevention informed by drug development and epidemiology
Daly, T. P. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0112 · Cited by 2
A 12-year comparison of patients with Alzheimer’s dementia with their informants in eight Asian countries
Jhang, K.-M., Dharmasaroja, P. A., Senanarong, V., Dominguez, J. C., Lam, L. C., Huo, Z., Meguro, K., Kasai, M., Shoji, M., Wei, C., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104204 · Cited by 2
Novel Thiadiazole Derivatives as Potential Anti‐Alzheimer Agent: Synthesis, Activity of Molecular Interactions and their in Silico Assessment
Du, W.-R., Lan, Y. J., Guo, X.-Y., Wei, B.-B., Wang, Y., Zhou, X.-W., & Ma, Z.-Y. (2024) · ChemistrySelect · doi:10.1002/slct.202402843 · Cited by 1
Alzheimer’s Disease and (Phyto) Estrogen Treatment: Modification of Effects by Age, Type of Treatment, and Duration of Use
Kuck, M. J., Begde, A., Hawkins, K., & Hogervorst, E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231415 · Cited by 1
Nanotechnology in Alzheimer’s
Mude, L., Swain, S. S., Karri, V. V. S. R., Kuppusamy, G., & Subramaniyan, V. (2024) · Springer eBooks · doi:10.1007/978-981-96-0259-9_11 · Cited by 1
The Use and Understanding of Mild Cognitive Impairment in Routine Specialist Care: A Survey Among German Memory Clinics
Benson, G. S., Bartels, C., Stamatis, F., Belz, M., Esselmann, H., Froelich, L., & Hausner, L. (2025) · Geriatrics · doi:10.3390/geriatrics10010021 · Cited by 1
Physical Activity Barriers and Facilitators for Older Women With Mild Cognitive Impairment and Alzheimer’s Disease
Tortosa‐Martínez, J., Martínez-Canales, C., Sanchís-Soler, G., & Beltrán‐Carrillo, V. J. (2025) · Journal of Aging and Physical Activity · doi:10.1123/japa.2024-0085 · Cited by 1
The effects of coagulation factors on the risk of Alzheimer’s disease: A Mendelian randomization study
Shi, W., Lu, J., Wei, P., Ning, P., Fan, J., Huang, S., Guo, X., & Li, R. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251327674 · Cited by 1
Case Report: Care of the Agitated Emergency Department Patient With Alzheimer’s Disease
Luciani‐Mcgillivray, I., Chen, A. C. N., & Normandin, P. A. (2025) · Journal of Emergency Nursing · doi:10.1016/j.jen.2025.04.002 · Cited by 1
Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using a Vision Transformer and Hippocampal MRI Slices
Seiger, R., Fierlinger, P., & Initiative, A. D. N. (2026) · Bioengineering · doi:10.3390/bioengineering13020163 · Cited by 2
Domino-like Effect of C112R Mutation on ApoE4 Aggregation and Its Reduction by Alzheimer’s Disease Drug CandidatePreprint
Nemergut, M., Marques, S. M., Uhrík, L., Váňová, T., Nezvedová, M., Gadara, D. C., Jha, D., Tulis, J., Novakova, V., Planas-Iglesias, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.09.511473 · Cited by 1
Exploring New Vista for Alzheimer's Disease Drug Targets (Part II)
Bolinger, A. A., & Zhou, J. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662313230626121232 · Cited by 1
Trail Making Test Part B as a Preclinical Indicator and Proxy for Spatial Navigation Change in Alzheimer's DiseasePreprint
Nevers, J. I. (2023) · Research Square · doi:10.21203/rs.3.rs-3318513/v1 · Cited by 1
New Genetic Loci Discovery for Alzheimer’s Disease Using Explainable Deep Neural NetworksPreprint
Gkertsou, C., Parameshwarappa, A. K., Shiyanbola, A., Balkhiyarova, Z., Kouchaki, S., Prokopenko, I., Lagou, V., & Demirkan, A. (2023) · Preprints.org · doi:10.1101/2023.12.11.23299839
Sex differences in the associations of socioeconomic factors and cognitive performance with family history of Alzheimer’s diseasePreprint
He, J., Cabrera‐Mendoza, B., Friligkou, E., Mecca, A. P., van Dyck, C. H., Pathak, G. A., & Polimanti, R. A. (2024) · medRxiv · doi:10.1101/2024.06.12.24308850 · Cited by 1
Editorial for a New Section: Nutrition and Neuro Sciences
Perrone, L., & Grant, W. B. (2025) · Nutrients · doi:10.3390/nu17091399 · Cited by 1
Uncovering the invisible giant: Amyloid ß plaques and their proposed association with waste removal in Alzheimer-affected human hippocampusPreprint
Fabian‐Fine, R., Roman, A. G., Winters, M. J., Lathram, K. J., Bennett, C. H., Kipingi, L. K., Brännare-Gran, S. M., Whitley, A. E., Paul, C. M., Altman, L. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.01.657219 · Cited by 1
Strategies for Neuroprotection in Alzheimer's Disease
Jasutkar, H. G. (2025) · Wiley eBooks · doi:10.1002/9783527844678.ch5 · Cited by 1
No Distinct Gut Microbiome Signature in Alzheimer’s Disease: A Reanalysis with Modern ToolsPreprint
Sakana, G. N., York, S., & Alcazar, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675220 · Cited by 1
“Like taking part in Star Wars”: A thematic analysis of acceptability and experiences of older adults participating in remote longitudinal sleep and dementia researchPreprint
Biswas, B., Gabb, V. G., Blackman, J., Morrison, H. D., Coulthard, E. J., & Roudaut, A. (2025) · medRxiv · doi:10.1101/2025.11.19.25340565 · Cited by 1
How common is Alzheimer’s? Blood-test study holds surprises
Mullard, A. (2025) · Nature · doi:10.1038/d41586-025-04133-x · Cited by 1
Making pre-screening for Alzheimer's disease (AD) and Postoperative delirium among post-acute COVID-19 syndrome - (PACS) a national priority: The Deep Neuro Study
Tarnanas, I., & Tsolaki, M. (2022) · Open Research Europe · doi:10.12688/openreseurope.15005.1
Insulin Resistance and the Brain–Novel Insights Combining Metabolic Research and Neuroscience
Ekblad, L. L., & Rebelos, E. (2022) · Metabolites · doi:10.3390/metabo12090780
APOE ε4 gene dose effect on imaging and blood biomarkers of glial reactivity and β-amyloid pathologyPreprint
Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.19.508484
Thyroid-stimulating hormone and the risk of Alzheimer's disease: an ADNI cohort studyPreprint
Zhang, B., Zhang, C., Xie, Y., Wang, Y., Chen, L., Qiao, Y., & Peng, D. (2022) · Research Square · doi:10.21203/rs.3.rs-2114827/v1
How Long-Term Care Quality Measures Address Alzheimer's Disease and Related Dementias in European Countries
Lepore, M., Zúñiga, F., Schols, J. M. G. A., Wingenfeld, K., van Achterberg, T., & Murray, B. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.02.107
Visual Memory and Spatial Navigation as Preclinical Indicators of Alzheimer's DiseasePreprint
Nevers, J. I. (2023) · Research Square · doi:10.21203/rs.3.rs-3253822/v1
The Trail Making Test Part B as a Preclinical Indicator of Alzheimer's Disease and Proxy for Spatial NavigationPreprint
Nevers, J. I. (2023) · Research Square · doi:10.21203/rs.3.rs-3256825/v1
Impact of Coconut Oil and its Bioactive Principles in Alzheimer’s disease and Dementia: A Systematic Review and Meta-AnalysisPreprint
Bafail, D. A., Bafail, A., Alshehri, N. F., Alhalees, N. H. Y., & Bajarwan, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3291861/v1
Knowledge-based intervention improves older adult recognition memory for novel activity, but not event segmentation or temporal order memory
Payne, K. B., Brazil, C. K., Apel, M., & Bailey, H. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-45577-3
Stigmatization of patients with neurocognitive disorder
Mihai, A., Marchean, H., Avărvăroaei, R.-I., & Molnar, D.-V.-N. (2023) · Psihiatru ro · doi:10.26416/psih.74.3.2023.8665
Acute Intermittent Hypoxia Therapy alters cognitive behavioral parameters in wistar albino rats
Roshan, S. A., Gunaseelan, D., Benazsir, S., Pandian, N., Jayachandran, S. K., Kandasamy, M., & Muthusamy, A. (2023) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2023.150512
Alzheimer's disease - The role of neuropsychology. Summary of recommendations for intervention and notes on future perspectives
Ribeiro, D. J. T., & Rocha, P. (2024) · International Journal of Health Science · doi:10.22533/at.ed.159442409011
Ameliorative Effects of Methanolic extract of Erythrina variegate in Scopolamine-Induced Amnesic in Adult Zebrafish (Daniorerio) Model
al., S. A. E. (2023) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2023.334657
Ensemble Learning with Time Accumulative Effect for Early Diagnosis of Alzheimer’s Disease
Zhou, Z., Yu, H. Z., & Wang, G. (2024) · Lecture notes in computer science · doi:10.1007/978-981-99-9119-8_13
APP and β-amyloid modulate protein aggregation and dissociation from recycling endosomal and exosomal membranesPreprint
Singh, P. J., Verma, B., Wells, A., Mendes, C. C., Dunn, D., Chen, Y.-N., Oh, J., Blincowe, L., Wainwright, S. M., Fischer, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.28.586966
A Graphene Field Effect Transistor (GFET) Based Integrated Biosensor System for Point-of-Care Application
Zhu, Z., Guo, B., Wang, J., Lou, F., & Lü, Y. (2024) · China Semiconductor Technology International Conference (CSTIC) · doi:10.1109/cstic61820.2024.10531910
CRISPR-Cas9 Gene Editing: A Promising Frontier in Revolutionizing Alzheimer’s Disease Management
Jin, Y. (2024) · MedScien · doi:10.61173/mfdht347
Altered T cell reactivity to β-amyloid-related antigens in early Alzheimer’s diseasePreprint
Rickenbach, C., Mallone, A., Häusle, L., Frei, L., Seiter, S., Sparano, C., Kirabali, T., Blennow, K., Zetterberg, H., Ferretti, M. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.04.597424
Self-citation
IPAD-DB: a manually curated database for experimentally verified inhibitors of proteins associated with Alzheimer’s disease
Peng, C., Liu, X., Meng, X., Chen, C., Wu, X., Bai, L., Lu, F., & Liu, F. (2024) · Database · doi:10.1093/database/baae048
The role of diabetes and vascular burden in Alzheimer’s disease
van Gils, V. (2024) · doi:10.26481/dis.20240628vg
A Data-Driven Boosting Cognitive Domain-Based Multimodal Framework for Alzheimer's Disease DiagnosisPreprint
Zhang, M., Cui, Q., Lü, Y., Yu, W., & Li, W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4873457
Therapeutic Role of Extracellular Vesicles in Neurodegenerative Disorders
Ganji, P., Prabhakar, S., & Manda, S. V. (2024) · Springer eBooks · doi:10.1007/978-981-97-2494-9_14
Biomarkers of neural integrity and immunoglobulin genes influence neurodegeneration in Alzheimer's disease
Pandey, J. P., Baglio, F., Mancuso, R., Guerini, F. R., Cabinio, M., Isernia, S., Clerici, M., & Agostini, S. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123167
Experimental studies linking Alzheimer's Disease and changes in immune cell function
Mingyu, M. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/47/2024pj0119
What patients in memory clinics want to know, and how we (ideally) inform them
Fruijtier, A. D. (2024) · doi:10.5463/thesis.698
Investigation of the expression of Cis P‐tau and Pin1 proteins following air pollution induction in the brain tissue of C57BL/6 mice
Shahpasand, S., Khatami, S. H., Ehtiati, S., Salmani, F., Zarei, T., Shahpasand, K., Ghobeh, M., & Karima, S. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2660
Biomarkers of Alzheimer’s Disease
Janakiraman, A. K., Chellammal, H. S. J., Raman, K., Ramkanth, S., Khanna, K., Ramachandran, D., Bhupathyraaj, M., & Cheng, Z. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_13-1
ALZHEIMER (AD) - A MULTIFACTORIAL NEURODEGENERATIVE DISEASE - A COHORT STUDY
Saragea, P. D., & Tudose, C. (2024) · Journal of Experimental and Molecular Biology · doi:10.47743/jemb-2024-210
Degenerative Brain Diseases and Acetylcholine and Gamma–Aminobutyric Acid Metabolism
Coşkunsu, S. (2024) · doi:10.69860/nobel.9786053359371.5
Biomarkers of Alzheimer’s Disease
Janakiraman, A. K., Chellammal, H. S. J., Raman, K., Ramkanth, S., Khanna, K., Ramachandran, D., Bhupathyraaj, M., & Cheng, Z. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_13
Primeval Identification and Diagnosis of Alzheimer's Disease Utilizing 3D CNN Models
Sujitha, K. L., Lynsha Helena Pratheeba, H. P., Rajeshwari, R., Ramaraj, K., Rajasekaran, M. P., & Thilagaraj, M. (2024) · International Conference on Advanced Computing and Communication Systems (ICACCS) · doi:10.1109/icaccs60874.2024.10717027
CNV-Profile Regression: A New Approach for Copy Number Variant Association Analysis in Whole Genome Sequencing DataPreprint
Si, Y., Lu, W., Holloway, S. T., Wang, H., Tucci, A. A., Brucker, A., Cheng, Y., Wang, L., Schellenberger, G., Lee, W., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.23.624994
ՄԻԿՐՈԳԼԻԱՅԻ ԵՎ ՈՍԿՐԱԾՈՒԾԻՑ ՍԵՐՎԱԾ ՄՈՆՈՑԻՏՆԵՐԻ ԴԵՐԸ ԱԼՑՀԵՅՄԵՐԻ ՀԻՎԱՆԴՈՒԹՅԱՆ ՊԱԹՈԳԵՆԵԶՈՒՄ
Գալստյան, Ս. Ա. (2024) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2024.38-7
The Effects of Bacopa Monnieri Extract Alone and in Combination with Ginkgo Biloba, Biotin and Coenzyme Q10 on Memory Impairment Induced by Scopolamine in MicePreprint
Rabbani, M., Abaei, M. K., & Hosseini-Sharifabad, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5092353
Effect of Yoga on Cognitive Enhancement in Individuals with Type 2 Diabetes Mellitus
Poongothai, S., Anjana, R. M., Swetha, K., & Mohan, V. (2025) · Journal of Diabetology · doi:10.4103/jod.jod_196_24
A 52-week, open-label, observational study evaluating tolerability, efficacy and physicians satisfaction of rivastigmine oral solution in Alzheimer's disease in Taiwan
Lee, C.-Y., Wang, W., Hsu, J.-L., Yang, Y., & Jhang, K.-M. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241311860
Vers un traitement neuroprotecteur dans la maladie de Parkinson ? La « cible alphasynucléine »
Damier, P. (2025) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2025.01.007
Cognitive markers of resilience to dementia in mild Neurocognitive Impairment: a meta- analysis
Raimo, S., Gaita, M., Cropano, M., Ammendola, L., Malangone, D., Torchia, V., Aquino, M., Roldán-Tapia, L., Trojano, L., & Santangelo, G. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08080-3
Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer’s disease (AD) via data fusion and machine learningPreprint
Gurmendi, D. S. M. R., Fumagal-González, G. A., Orozco-Sanchez, J., Farber, J., Treviño, V., Martínez-Ledesma, E., Martínez‐Torteya, A., Rosales-Gurmendi, F., Tamez‐Peña, J. G., & Initiative, A. D. N. (2025) · medRxiv · doi:10.1101/2025.03.11.25323801
Alzheimer’s Disease Mutations Disrupt Neural Stem Cell Fate and Early Brain DevelopmentPreprint
Wang, Y., Lorentz, J., Mohammadi, E., Yilmaz, D. E., Sgouras, T., Guo, Y., Pizzirusso, G., Demetriou, A., Nalvarte, I., Schultzberg, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.16.643546 · Cited by 1
Development and Validation of an HPLC Method to Determine Chemical and Radiochemical Purity of [18F]Florbetazine Injection
Wu, F., Wang, X., Chen, H., Zhou, X., Zhao, H., & Cui, M. (2025) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.4140
Mapping Amyloid Networks in Alzheimer’s Disease: A High-Order ICA Approach to Gray and White Matter PathologyPreprint
Khasayeva, N., Jensen, K. M., Eierud, C., Petropoulos, H., Levey, A. I., Lah, J. J., Luo, R., Premi, E., Borroni, B., Chen, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.21.644614
Enhancing Alzheimer's Disease Detection Through Electroencephalography Channel and Feature Optimization
Dimici, C., Katircioğlu, B., & Semiz, B. (2024) · Asilomar Conference on Signals, Systems and Computers (ACSSC) · doi:10.1109/ieeeconf60004.2024.10942752
Your Alzheimer Risk
Collij, L. E., & Mastenbroek, S. E. (2025) · Neurology · doi:10.1212/wnl.0000000000213622

Authors: Gustavsson, A., Norton, N., Fast, T., Frölich, L., Georges, J., Holzapfel, D., Kirabali, T., Krolak‐Salmon, P., Rossini, P. M., Ferretti, M. T., Lanman, L., Chadha, A. S., & van der Flier, W. M.
Affiliations: Karolinska Institutet (SE)
Quantify Research (Sweden) (SE)
Heidelberg University (DE)
Alzheimer Europe (LU)
CEO Initiative on Alzheimer's Disease Philadelphia USA
Biogen (Switzerland) (CH)
Hospices Civils de Lyon (FR)
Università Cattolica del Sacro Cuore (IT)
Women's Brain Project (CH)
F. Hoffmann-La Roche AG (CH)
Alzheimer Center Amsterdam Department of Neurology Department of Epidemiology and Data Science Amsterdam Neuroscience Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam the Netherlands
Corresponding author: Gustavsson, Anders
ORCID: Gustavsson, Anders
Norton, Nicholas
Georges, Jean
Kirabali, Tunahan
Krolak‐Salmon, Pierre
Rossini, Paolo M.
Ferretti, Maria Teresa
Chadha, Antonella Santuccione
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2022-06-02
Volume: 19
Issue: 2
Pages: 658-670
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1002/alz.12694
OpenAlex: W4281674975
Cited by: 895
References: 62
Citations by year: 2026: 207 · 2025: 323 · 2024: 236 · 2023: 114 · 2022: 15
FWCI: 112.57
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
creativecommons.org/licenses/by-nc/4.0/ (vor)
Locations: Alzheimer s & Dementia (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion, other-oa)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders: F. Hoffmann-La Roche
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords: Alzheimer's disease, Alzheimer's disease continuum
MeSH terms: Alzheimer Disease, Humans, Biomarkers, Prevalence, Prodromal Symptoms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Global estimates on the number of persons across the Alzheimer's disease continuum

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks